Latest news

partners4access-launch-weekly-newsletter-focusing-on-market-access-and-rare-diseases

Partners4Access launch weekly newsletter focusing on market access and rare diseases

Partners4Access (P4A), the specialists in orphan drug access, are launching a weekly newsletter focussing on key developments in the rare diseases and orphan drugs market access landscape. The service will offer a comprehensive weekly summary of the most interesting and relevant news articles, beginning on Thursday 16th November 2017. The newsletter will allow readers to […]

Read More


p4as-sophie-schmitz-presents-key-insights-on-gene-therapy-at-wodc-2017

P4A’s Sophie Schmitz presents key insights on Gene Therapy at WODC 2017

Sophie Schmitz, Managing Partner of Partners4Access, the specialists in orphan drug access, is presenting at the 8th annual meeting of the World Orphan Drug Congress in Barcelona on November 15, 2017 on Gene Therapy. Schmitz will be reviewing the potential of Gene Therapy to revolutionise the healthcare industry, highlighting recent successes and discussing key challenges. “Gene […]

Read More


meet-partners4access-at-ispor-2017-to-discuss-their-latest-research

Meet Partners4Access at ISPOR 2017 to discuss their latest research

Partners4Access (P4A) the specialists in orphan drug access, are presenting 3 posters at the International Society for Pharmacoeconomics and Outcomes Research’s (ISPOR) 20th European Congress in Glasgow from 4th to 8th November 2017. Select members of the Partners4Access specialist team will be presenting the posters in person: Evaluation Framework for digital medicines in Europe (A […]

Read More


partners4access-launches-new-webinar-series-on-gene-therapy-are-we-ready-yet

Partners4Access launches new Webinar Series on Gene Therapy – Are we ready yet?

Partners4Access (P4A), the specialists in orphan drug access, are launching a new webinar series, in line with their expanding activities in gene therapy. Launching in November 2017,  P4A invites participants to register now to secure their place for this inaugural webinar. As with most innovative and novel areas, gene therapy is facing misconceptions guided by hopes, […]

Read More


european-pmaa-consolidation-a-paradigm-shift-and-implications-for-pharma

European P&MA Consolidation: A Paradigm Shift and Implications for Pharma

Earlier this month, Italy’s Health Minister, Beatrice Lorenzin, announced that two additional countries- Slovenia and Croatia- had signed up to the Valletta Declaration. Of the 28 EU member states, over a third (10 countries*) are now part of the initiative which aims to strengthen their bargaining power over pharmaceutical companies through collective price negotiations and […]

Read More


p4a-attends-the-festival-of-genomics-in-boston

P4A attends the Festival of Genomics in Boston

Partners4Access will attend the Festival of Genomics in Boston on October 3rd, 2017. Sophie Schmitz, Managing Partner at P4A will be there meeting representatives of the research and patient community as well as the pharmaceutical industry. The Festival celebrates the achievements made within genomics and human health. The 1200 attendees aim to “shape ideas, challenge […]

Read More


p4a-participated-at-the-vecht-voor-kinderen-rally

P4A participated at the Vecht voor Kinderen Rally

At the weekend (17/06), Sophie participated in the Dutch Vecht voor Kinderen Rally (fight for children rally), supporting a number of children charities including a children’s hospice, child cancer organisation that provides children with wigs and various development programmes in Africa. Those sponsoring and charity activities have a long tradition  at Partners4Access, in particular supporting […]

Read More


sophie-schmitz-attended-world-orphan-drug-congress

Sophie Schmitz attended world orphan drug congress

Many rare disease patients lay their hope in gene-therapy development. However, recent experience with Glybera (uniQure) has shown difficulties faced in the launch and access. During the World Orphan Drug Congress in Washington this month, Partners4Access had the opportunity to get latest insights from a German sickness fund that reimbursed Glybera and the CEO of […]

Read More


partners4access-is-pleased-to-announce-the-addition-of-rosa-pandolfo-to-the-london-office

Partners4Access is pleased to announce the addition of Rosa Pandolfo to the London office

Continued focus is ‘Orphan Drug Solutions’ a partnership approach to ensuring a successful global launch. Partners4Access, the global access experts for orphan drugs, is pleased to announce that Rosa Pandolfo joined the company’s London Office as Senior Consultant. This addition helps further secure P4A’s position as the go-to partner for orphan drug manufacturers. Schmitz, Managing […]

Read More


Partners4Access collaborates with Cambridge University

          Partners4Access, the global access experts for orphan drugs, has entered into a collaboration with Cambridge University to support their Graduate Professional Practice Programme.  Partners4Access will support a student from the Masters in Bioscience Enterprise program develop their dissertation, providing a platform to engage in a corporate-level environment.  Sophie Schmitz, Managing Partner at Partners4Access said, […]

Read More